Onconetix (ONCO) Pension (2023 - 2025)
Onconetix (ONCO) posted quarterly Pension of $73644.0 for Q2 2025, down 80.38% year-over-year from $375360.0 in Q2 2024, and down 66.4% quarter-over-quarter from $219161.0 in Q1 2025.
Onconetix (ONCO) Pension (2023 - 2025) Analysis & Trends
Onconetix (ONCO) has reported Pension for 3 consecutive years, with $73644.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Pension fell 80.38% year-over-year to $73644.0; the TTM figure through Jun 2025 stood at $73644.0 (down 80.38% YoY), while the FY2024 annual figure was $280879.0, down 49.51% from the prior year.
- Pension retreated to $73644.0 in Q2 2025 per ONCO's latest filing, from $219161.0 in the prior quarter.
- Across five years, Pension topped out at $556296.0 in Q4 2023 and bottomed at $73644.0 in Q2 2025.
- Historically, Pension has averaged $335520.9 across 3 years, with a median of $321132.0 in 2024.
- On a YoY basis, Pension climbed as much as 31.75% in 2025 and fell as far as 80.38% in 2025.
- Onconetix's Pension stood at $556296.0 in 2023, then slumped by 49.51% to $280879.0 in 2024, then plunged by 73.78% to $73644.0 in 2025.
- Business Quant data shows ONCO's Pension at $73644.0 in Q2 2025, $219161.0 in Q1 2025, and $280879.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 73,644.00 |
| Mar 31, 2025 | 219,161.00 |
| Dec 31, 2024 | 280,879.00 |
| Sep 30, 2024 | 522,174.00 |
| Jun 30, 2024 | 375,360.00 |
| Mar 31, 2024 | 321,132.00 |
| Dec 31, 2023 | 556,296.00 |